头颈癌放疗后晚期吞咽困难的风险器官识别
BACKGROUND AND PURPOSE: Dysphagia is a common, severe and dose-limiting toxicity after oncological treatment of head and neck cancer (HNC).…
要点
- 对侧腮腺平均剂量、声门上喉平均剂量和对侧二腹肌前腹最大剂量可预测患者报告的吞咽困难。
- 咽缩肌、喉、声门上喉和会厌平均剂量及对侧颌下腺最大剂量可预测视频透视下的中重度吞咽困难。
- 会厌和颌下腺剂量是除已知吞咽风险器官外的新发现,需外部验证。
核心结论
- 除已知吞咽风险器官外,会厌和颌下腺剂量对放疗后吞咽功能重要,保持DVH阈值低于V60=60%和V60=17%可能减少严重晚期吞咽困难。
主要发现
- 中位评估时间为放疗后7个月(范围5-34个月)。
- 对侧腮腺平均剂量、声门上喉平均剂量和对侧二腹肌前腹最大剂量预测患者报告的吞咽困难(AUC=0.64-0.67)。
- 咽缩肌、喉、声门上喉和会厌平均剂量及对侧颌下腺最大剂量预测视频透视下的中度和重度吞咽困难(AUC=0.71-0.80)。
关键数值与推荐
- 视频透视下中重度吞咽困难定义为穿透-误吸量表(PAS)≥4/≥6。
- 保持会厌V60≤60%和颌下腺V60≤17%可能降低严重晚期吞咽困难发生。
临床怎么用
- 在头颈癌放疗计划优化时,除已知吞咽风险器官外,可考虑将会厌和颌下腺剂量约束纳入考量。
局限性
- 结果需在未来研究中外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Dysphagia is a common, severe and dose-limiting toxicity after oncological treatment of head and neck cancer (HNC). This study aims to investigate relationships between radiation doses to structures involved in normal swallowing and patient-reported as well as clinically measured swallowing function in HNC patients after curative (chemo-) radiation therapy (RT) with focus on late effects. MATERIALS AND METHODS: Patients (n = 90) with HNC curatively treated with RT ± chemotherapy in 2007-2015 were assessed for dysphagia post-treatment by telephone interview and videofluoroscopy (VFS). A study-specific symptom score was used to determine patient-reported dysphagia. The Penetration-Aspiration Scale (PAS) was applied to determine swallowing function by VFS (PAS ≥ 4/ ≥ 6 = moderate/severe dysphagia). Thirteen anatomical structures involved in normal swallowing were individually delineated on the patients' original planning CT scans and associated dose-volume histograms (DVHs) retrieved. Relationships between structure doses and late toxicity were investigated through univariable and multivariable logistic regression analysis (UVA/MVA) accounting for effects by relevant clinical factors. RESULTS: Median assessment time was 7 months post-RT (range: 5-34 months). Mean dose to the contralateral parotid gland and supraglottic larynx as well as maximum dose to the contralateral anterior digastric muscle predicted patient-reported dysphagia (AUC = 0.64-0.67). Mean dose to the pharyngeal constrictor muscle, the larynx, the supraglottic larynx and the epiglottis, as well as maximum dose to the contralateral submandibular gland predicted moderate and severe dysphagia by VFS (AUC = 0.71-0.80). CONCLUSION: The patients in this cohort were consecutively identified pre-treatment, and were structurally approached and assessed for dysphagia after treatment at a specific time point. In addition to established dysphagia organs-at-risk (OARs), our data suggest that epiglottic and submandibular gland doses are important for swallowing function post-RT. Keeping DVH thresholds below V60 = 60% and V60 = 17%, respectively, may increase chances to reduce occurrence of severe late dysphagia. The results need to be externally validated in future studies.
引用
- Hedström J, Tuomi L, Finizia C, et al. Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients. Clin Transl Radiat Oncol. 2019. PMID: 31646203. doi:10.1016/j.ctro.2019.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。